img

Global and India Newborn Screening for SMA and SCID Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Newborn Screening for SMA and SCID Market Report & Forecast 2024-2034

Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Market Analysis and InsightsGlobal and India Newborn Screening for SMA and SCID Market
This report focuses on global and India Newborn Screening for SMA and SCID market, also covers the segmentation data of other regions in regional level and county level.
The global Newborn Screening for SMA and SCID revenue was US$ 129.2 million in 2024 and is forecast to a readjusted size of US$ 288 million by 2034 with a CAGR of 11.5% during the review period (2024-2034).
Global key players of newborn screening for SMA and SCID include Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics, etc. The top three players hold a share over 85%. North America is the largest market, has a share about 60%, followed by Europe, with share 25%.
Global Newborn Screening for SMA and SCID Scope and Market Size
Newborn Screening for SMA and SCID market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Newborn Screening for SMA and SCID market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For India market, this report focuses on the Newborn Screening for SMA and SCID market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Segment by Type
Instruments
Kits
Software

Segment by Application


SCID Screening
SMA Screening
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Newborn Screening for SMA and SCID definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Newborn Screening for SMA and SCID companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Newborn Screening for SMA and SCID in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Newborn Screening for SMA and SCID revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Newborn Screening for SMA and SCID Product Introduction
1.2 Global Newborn Screening for SMA and SCID Outlook 2018 VS 2024 VS 2034
1.2.1 Global Newborn Screening for SMA and SCID Market Size for the Year 2018-2034
1.2.2 India Newborn Screening for SMA and SCID Market Size for the Year 2018-2034
1.3 Newborn Screening for SMA and SCID Market Size, India VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of India Newborn Screening for SMA and SCID in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Newborn Screening for SMA and SCID Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4 Newborn Screening for SMA and SCID Market Dynamics
1.4.1 Newborn Screening for SMA and SCID Industry Trends
1.4.2 Newborn Screening for SMA and SCID Market Drivers
1.4.3 Newborn Screening for SMA and SCID Market Challenges
1.4.4 Newborn Screening for SMA and SCID Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Newborn Screening for SMA and SCID by Type
2.1 Newborn Screening for SMA and SCID Market Segment by Type
2.1.1 Instruments
2.1.2 Kits
2.1.3 Software
2.2 Global Newborn Screening for SMA and SCID Market Size by Type (2018, 2024 & 2034)
2.3 Global Newborn Screening for SMA and SCID Market Size by Type (2018-2034)
2.4 India Newborn Screening for SMA and SCID Market Size by Type (2018, 2024 & 2034)
2.5 India Newborn Screening for SMA and SCID Market Size by Type (2018-2034)
3 Newborn Screening for SMA and SCID by Application
3.1 Newborn Screening for SMA and SCID Market Segment by Application
3.1.1 SCID Screening
3.1.2 SMA Screening
3.2 Global Newborn Screening for SMA and SCID Market Size by Application (2018, 2024 & 2034)
3.3 Global Newborn Screening for SMA and SCID Market Size by Application (2018-2034)
3.4 India Newborn Screening for SMA and SCID Market Size by Application (2018, 2024 & 2034)
3.5 India Newborn Screening for SMA and SCID Market Size by Application (2018-2034)
4 Global Newborn Screening for SMA and SCID Competitor Landscape by Company
4.1 Global Newborn Screening for SMA and SCID Market Size by Company
4.1.1 Global Key Companies of Newborn Screening for SMA and SCID, Ranked by Revenue (2024)
4.1.2 Global Newborn Screening for SMA and SCID Revenue by Player (2018-2023)
4.2 Global Newborn Screening for SMA and SCID Concentration Ratio (CR)
4.2.1 Newborn Screening for SMA and SCID Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Newborn Screening for SMA and SCID in 2024
4.2.3 Global Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Newborn Screening for SMA and SCID Head office and Area Served
4.4 Global Key Players of Newborn Screening for SMA and SCID, Product and Application
4.5 Global Key Players of Newborn Screening for SMA and SCID, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Newborn Screening for SMA and SCID Market Size by Company
4.7.1 Key Players of Newborn Screening for SMA and SCID in India, Ranked by Revenue (2024)
4.7.2 India Newborn Screening for SMA and SCID Revenue by Players (2021, 2024 & 2023)
5 Global Newborn Screening for SMA and SCID Market Size by Region
5.1 Global Newborn Screening for SMA and SCID Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Newborn Screening for SMA and SCID Market Size by Region (2018-2034)
5.2.1 Global Newborn Screening for SMA and SCID Market Size by Region: 2018-2023
5.2.2 Global Newborn Screening for SMA and SCID Market Size by Region (2024-2034)
6 Americas
6.1 Americas Newborn Screening for SMA and SCID Market Size YoY Growth 2018-2034
6.2 Americas Newborn Screening for SMA and SCID Market Size by Type
6.2.1 Americas Newborn Screening for SMA and SCID Market Size by Type (2018-2023)
6.2.2 Americas Newborn Screening for SMA and SCID Market Size by Type (2024-2034)
6.2.3 Americas Newborn Screening for SMA and SCID Market Share by Type (2018-2034)
6.3 Americas Newborn Screening for SMA and SCID Market Size by Application
6.3.1 Americas Newborn Screening for SMA and SCID Market Size by Application (2018-2023)
6.3.2 Americas Newborn Screening for SMA and SCID Market Size by Application (2024-2034)
6.3.3 Americas Newborn Screening for SMA and SCID Market Share by Application (2018-2034)
6.4 Americas Newborn Screening for SMA and SCID Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Newborn Screening for SMA and SCID Market Size YoY Growth 2018-2034
7.2 EMEA Newborn Screening for SMA and SCID Market Size by Type
7.2.1 EMEA Newborn Screening for SMA and SCID Market Size by Type (2018-2023)
7.2.2 EMEA Newborn Screening for SMA and SCID Market Size by Type (2024-2034)
7.2.3 EMEA Newborn Screening for SMA and SCID Market Share by Type (2018-2034)
7.3 EMEA Newborn Screening for SMA and SCID Market Size by Application
7.3.1 EMEA Newborn Screening for SMA and SCID Market Size by Application (2018-2023)
7.3.2 EMEA Newborn Screening for SMA and SCID Market Size by Application (2024-2034)
7.3.3 EMEA Newborn Screening for SMA and SCID Market Share by Application (2018-2034)
7.4 EMEA Newborn Screening for SMA and SCID Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Newborn Screening for SMA and SCID Market Size YoY Growth 2018-2034
8.2 China Newborn Screening for SMA and SCID Market Size by Type
8.2.1 China Newborn Screening for SMA and SCID Market Size by Type (2018-2023)
8.2.2 China Newborn Screening for SMA and SCID Market Size by Type (2024-2034)
8.2.3 China Newborn Screening for SMA and SCID Market Share by Type (2018-2034)
8.3 China Newborn Screening for SMA and SCID Market Size by Application
8.3.1 China Newborn Screening for SMA and SCID Market Size by Application (2018-2023)
8.3.2 China Newborn Screening for SMA and SCID Market Size by Application (2024-2034)
8.3.3 China Newborn Screening for SMA and SCID Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Newborn Screening for SMA and SCID Market Size YoY Growth 2018-2034
9.2 APAC Newborn Screening for SMA and SCID Market Size by Type
9.2.1 APAC Newborn Screening for SMA and SCID Market Size by Type (2018-2023)
9.2.2 APAC Newborn Screening for SMA and SCID Market Size by Type (2024-2034)
9.2.3 APAC Newborn Screening for SMA and SCID Market Share by Type (2018-2034)
9.3 APAC Newborn Screening for SMA and SCID Market Size by Application
9.3.1 APAC Newborn Screening for SMA and SCID Market Size by Application (2018-2023)
9.3.2 APAC Newborn Screening for SMA and SCID Market Size by Application (2024-2034)
9.3.3 APAC Newborn Screening for SMA and SCID Market Share by Application (2018-2034)
9.4 APAC Newborn Screening for SMA and SCID Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Perkinelmer
10.1.1 Perkinelmer Company Details
10.1.2 Perkinelmer Business Overview
10.1.3 Perkinelmer Newborn Screening for SMA and SCID Introduction
10.1.4 Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2018-2023)
10.1.5 Perkinelmer Recent Development
10.2 Thermo Fisher
10.2.1 Thermo Fisher Company Details
10.2.2 Thermo Fisher Business Overview
10.2.3 Thermo Fisher Newborn Screening for SMA and SCID Introduction
10.2.4 Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2018-2023)
10.2.5 Thermo Fisher Recent Development
10.3 ImmunoIVD
10.3.1 ImmunoIVD Company Details
10.3.2 ImmunoIVD Business Overview
10.3.3 ImmunoIVD Newborn Screening for SMA and SCID Introduction
10.3.4 ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2018-2023)
10.3.5 ImmunoIVD Recent Development
10.4 Labsystems Diagnostics
10.4.1 Labsystems Diagnostics Company Details
10.4.2 Labsystems Diagnostics Business Overview
10.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Introduction
10.4.4 Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2018-2023)
10.4.5 Labsystems Diagnostics Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Newborn Screening for SMA and SCID Market Size India VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Newborn Screening for SMA and SCID Market Trends
Table 3. Newborn Screening for SMA and SCID Market Drivers
Table 4. Newborn Screening for SMA and SCID Market Challenges
Table 5. Newborn Screening for SMA and SCID Market Restraints
Table 6. Global Newborn Screening for SMA and SCID Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Newborn Screening for SMA and SCID Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Newborn Screening for SMA and SCID Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Newborn Screening for SMA and SCID Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Newborn Screening for SMA and SCID, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Newborn Screening for SMA and SCID Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Newborn Screening for SMA and SCID Revenue Share by Player, 2018-2023
Table 13. Global Newborn Screening for SMA and SCID Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Newborn Screening for SMA and SCID by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2024)
Table 15. Global Key Players of Newborn Screening for SMA and SCID, Headquarters and Area Served
Table 16. Global Key Players of Newborn Screening for SMA and SCID, Product and Application
Table 17. Global Key Players of Newborn Screening for SMA and SCID, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Newborn Screening for SMA and SCID in India, Ranked by Revenue (2024) & (US$ Million)
Table 20. India Newborn Screening for SMA and SCID Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. India Newborn Screening for SMA and SCID Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Newborn Screening for SMA and SCID Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Newborn Screening for SMA and SCID Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Newborn Screening for SMA and SCID Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Newborn Screening for SMA and SCID Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Newborn Screening for SMA and SCID Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Newborn Screening for SMA and SCID Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Newborn Screening for SMA and SCID Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Newborn Screening for SMA and SCID Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Newborn Screening for SMA and SCID Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Newborn Screening for SMA and SCID Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Newborn Screening for SMA and SCID Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Newborn Screening for SMA and SCID Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Newborn Screening for SMA and SCID Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Newborn Screening for SMA and SCID Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Newborn Screening for SMA and SCID Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Newborn Screening for SMA and SCID Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Newborn Screening for SMA and SCID Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Newborn Screening for SMA and SCID Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Newborn Screening for SMA and SCID Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Newborn Screening for SMA and SCID Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Newborn Screening for SMA and SCID Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Newborn Screening for SMA and SCID Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Newborn Screening for SMA and SCID Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Newborn Screening for SMA and SCID Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Newborn Screening for SMA and SCID Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Newborn Screening for SMA and SCID Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Newborn Screening for SMA and SCID Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Newborn Screening for SMA and SCID Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Newborn Screening for SMA and SCID Market Size by Region (2024-2034) & (US$ Million)
Table 51. Perkinelmer Company Details
Table 52. Perkinelmer Business Overview
Table 53. Perkinelmer Newborn Screening for SMA and SCID Product
Table 54. Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2018-2023) & (US$ Million)
Table 55. Perkinelmer Recent Development
Table 56. Thermo Fisher Company Details
Table 57. Thermo Fisher Business Overview
Table 58. Thermo Fisher Newborn Screening for SMA and SCID Product
Table 59. Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2018-2023) & (US$ Million)
Table 60. Thermo Fisher Recent Development
Table 61. ImmunoIVD Company Details
Table 62. ImmunoIVD Business Overview
Table 63. ImmunoIVD Newborn Screening for SMA and SCID Product
Table 64. ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2018-2023) & (US$ Million)
Table 65. ImmunoIVD Recent Development
Table 66. Labsystems Diagnostics Company Details
Table 67. Labsystems Diagnostics Business Overview
Table 68. Labsystems Diagnostics Newborn Screening for SMA and SCID Product
Table 69. Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2018-2023) & (US$ Million)
Table 70. Labsystems Diagnostics Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Newborn Screening for SMA and SCID Product Picture
Figure 2. Global Newborn Screening for SMA and SCID Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Newborn Screening for SMA and SCID Market Size 2018-2034 (US$ Million)
Figure 4. India Newborn Screening for SMA and SCID Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. India Newborn Screening for SMA and SCID Market Size 2018-2034 (US$ Million)
Figure 6. India Newborn Screening for SMA and SCID Market Share in Global 2018-2034
Figure 7. Newborn Screening for SMA and SCID Report Years Considered
Figure 8. Product Picture of Instruments
Figure 9. Product Picture of Kits
Figure 10. Product Picture of Software
Figure 11. Global Newborn Screening for SMA and SCID Market Share by Type in 2024 & 2034
Figure 12. Global Newborn Screening for SMA and SCID Market Size by Type (2018-2034) & (US$ Million)
Figure 13. Global Newborn Screening for SMA and SCID Market Share by Type (2018-2034)
Figure 14. India Newborn Screening for SMA and SCID Market Share by Type in 2024 & 2034
Figure 15. India Newborn Screening for SMA and SCID Market Size by Type (2018-2034) & (US$ Million)
Figure 16. India Newborn Screening for SMA and SCID Market Share by Type (2018-2034)
Figure 17. Product Picture of SCID Screening
Figure 18. Product Picture of SMA Screening
Figure 19. Global Newborn Screening for SMA and SCID Market Share by Application in 2024 & 2034
Figure 20. Global Newborn Screening for SMA and SCID Market Size by Application (2018-2034) & (US$ Million)
Figure 21. Global Newborn Screening for SMA and SCID Market Share by Application (2018-2034)
Figure 22. India Newborn Screening for SMA and SCID Market Share by Application in 2024 & 2034
Figure 23. India Newborn Screening for SMA and SCID Market Size by Application (2018-2034) & (US$ Million)
Figure 24. India Newborn Screening for SMA and SCID Market Share by Application (2018-2034)
Figure 25. The Top 5 and 10 Largest Companies of Newborn Screening for SMA and SCID in the World: Market Share by Newborn Screening for SMA and SCID Revenue in 2024
Figure 26. Global Newborn Screening for SMA and SCID Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 27. Global Newborn Screening for SMA and SCID Market Share by Region (2018-2034)
Figure 28. Americas Newborn Screening for SMA and SCID Market Size Growth Rate 2018-2034 (US$ Million)
Figure 29. Americas Newborn Screening for SMA and SCID Market Share by Type (2018-2034)
Figure 30. Americas Newborn Screening for SMA and SCID Market Share by Application (2018-2034)
Figure 31. United States Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 32. Canada Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 33. Mexico Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 34. Brazil Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. EMEA Newborn Screening for SMA and SCID Market Size Growth Rate 2018-2034 (US$ Million)
Figure 36. EMEA Newborn Screening for SMA and SCID Market Share by Type (2018-2034)
Figure 37. EMEA Newborn Screening for SMA and SCID Market Share by Application (2018-2034)
Figure 38. Europe Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 39. Middle East Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 40. Africa Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 41. China Newborn Screening for SMA and SCID Market Size Growth Rate 2018-2034 (US$ Million)
Figure 42. China Newborn Screening for SMA and SCID Market Share by Type (2018-2034)
Figure 43. China Newborn Screening for SMA and SCID Market Share by Application (2018-2034)
Figure 44. APAC Newborn Screening for SMA and SCID Market Size Growth Rate 2018-2034 (US$ Million)
Figure 45. APAC Newborn Screening for SMA and SCID Market Share by Type (2018-2034)
Figure 46. APAC Newborn Screening for SMA and SCID Market Share by Application (2018-2034)
Figure 47. Japan Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 48. South Korea Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 49. China Taiwan Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 50. Southeast Asia Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. India Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. Perkinelmer Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2018-2023)
Figure 53. Thermo Fisher Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2018-2023)
Figure 54. ImmunoIVD Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2018-2023)
Figure 55. Labsystems Diagnostics Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed